KR20200103718A - 인간 피부 섬유아세포의 분리 방법 - Google Patents

인간 피부 섬유아세포의 분리 방법 Download PDF

Info

Publication number
KR20200103718A
KR20200103718A KR1020207019897A KR20207019897A KR20200103718A KR 20200103718 A KR20200103718 A KR 20200103718A KR 1020207019897 A KR1020207019897 A KR 1020207019897A KR 20207019897 A KR20207019897 A KR 20207019897A KR 20200103718 A KR20200103718 A KR 20200103718A
Authority
KR
South Korea
Prior art keywords
fibroblasts
human skin
human
cells
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020207019897A
Other languages
English (en)
Korean (ko)
Inventor
피오나 와트
크리스티나 필리페오스
마그너스 린츠
Original Assignee
킹스칼리지런던
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 킹스칼리지런던 filed Critical 킹스칼리지런던
Publication of KR20200103718A publication Critical patent/KR20200103718A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656—Adult fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C12N2509/10—Mechanical dissociation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020207019897A 2017-12-22 2018-12-21 인간 피부 섬유아세포의 분리 방법 Ceased KR20200103718A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1721738.1A GB201721738D0 (en) 2017-12-22 2017-12-22 Method
GB1721738.1 2017-12-22
PCT/GB2018/053760 WO2019122931A1 (en) 2017-12-22 2018-12-21 Method for isolating human dermal fibroblasts

Publications (1)

Publication Number Publication Date
KR20200103718A true KR20200103718A (ko) 2020-09-02

Family

ID=61131714

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020207019897A Ceased KR20200103718A (ko) 2017-12-22 2018-12-21 인간 피부 섬유아세포의 분리 방법

Country Status (6)

Country Link
US (2) US20210095252A1 (https=)
EP (1) EP3728565A1 (https=)
JP (2) JP7475685B2 (https=)
KR (1) KR20200103718A (https=)
GB (1) GB201721738D0 (https=)
WO (1) WO2019122931A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230074037A (ko) * 2021-11-18 2023-05-26 의료법인 성광의료재단 세포 노화 바이오 마커 syne2 또는 hmgb2, 및 이를 이용한 세포 노화를 검출하는 방법

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202104130D0 (en) * 2021-03-24 2021-05-05 King S College London Method
CN115058388A (zh) * 2022-03-14 2022-09-16 福建医科大学附属协和医院 间充质干细胞创面修复优势功能亚群及其鉴定和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801979B1 (fr) 1999-12-03 2002-02-08 Oreal Utilisation d'un anticorps specifique des fibroblastes papillaires comme marqueur de qualite d'une peau
US9074190B2 (en) 2003-10-07 2015-07-07 Biomaster, Inc. Cell differentiation of adipose-derived precursor cells
US20070065415A1 (en) * 2005-09-16 2007-03-22 Kleinsek Donald A Compositions and methods for the augmentation and repair of defects in tissue
JP6042904B2 (ja) 2011-11-25 2016-12-14 シャネル パフュームズ ビューテ 乳頭状および網状の線維芽細胞の新規マーカーおよびその使用

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230074037A (ko) * 2021-11-18 2023-05-26 의료법인 성광의료재단 세포 노화 바이오 마커 syne2 또는 hmgb2, 및 이를 이용한 세포 노화를 검출하는 방법
KR20230074030A (ko) * 2021-11-18 2023-05-26 의료법인 성광의료재단 세포 노화 바이오 마커 mmp15, acsl5 또는 cd36, 및 이를 이용한 세포 노화를 검출하기 위한 조성물
KR20230074038A (ko) * 2021-11-18 2023-05-26 의료법인 성광의료재단 세포 노화 바이오 마커 cdca7l 또는 wdr76, 및 이를 이용한 세포 노화를 검출하는 방법
KR20230074029A (ko) * 2021-11-18 2023-05-26 의료법인 성광의료재단 세포 노화 바이오 마커 cdca7l, wdr76 또는 h2bc8, 및 이를 이용한 세포 노화를 검출하기 위한 조성물
KR20230074027A (ko) * 2021-11-18 2023-05-26 의료법인 성광의료재단 세포 노화 바이오 마커 ezh2, tmpo 또는 amot, 및 이를 이용한 세포 노화를 검출하기 위한 조성물
KR20230074028A (ko) * 2021-11-18 2023-05-26 의료법인 성광의료재단 세포 노화 바이오 마커 gas2l3, syne2 또는 hmgb2, 및 이를 이용한 세포 노화를 검출하기 위한 조성물
KR20230074035A (ko) * 2021-11-18 2023-05-26 의료법인 성광의료재단 세포 노화 바이오 마커 ezh2 또는 tmpo, 및 이를 이용한 세포 노화를 검출하는 방법
KR20230074040A (ko) * 2021-11-18 2023-05-26 의료법인 성광의료재단 세포 노화 바이오 마커 acsl5 또는 cd36, 및 이를 이용한 세포 노화를 검출하는 방법
KR20230074031A (ko) * 2021-11-18 2023-05-26 의료법인 성광의료재단 세포 노화 바이오 마커 pld1, cyp26b1 또는 gsap, 및 이를 이용한 세포 노화를 검출하기 위한 조성물

Also Published As

Publication number Publication date
WO2019122931A1 (en) 2019-06-27
GB201721738D0 (en) 2018-02-07
JP2021507714A (ja) 2021-02-25
US20240279609A1 (en) 2024-08-22
JP2024038101A (ja) 2024-03-19
EP3728565A1 (en) 2020-10-28
JP7475685B2 (ja) 2024-04-30
US20210095252A1 (en) 2021-04-01

Similar Documents

Publication Publication Date Title
Philippeos et al. Spatial and single-cell transcriptional profiling identifies functionally distinct human dermal fibroblast subpopulations
US20240279609A1 (en) Method for isolating human dermal fibroblasts
Ali et al. Skin equivalents: skin from reconstructions as models to study skin development and diseases
Zhang et al. A review of adipocyte lineage cells and dermal papilla cells in hair follicle regeneration
TWI849298B (zh) 促進毛髮再生的富粒線體血漿、其製造方法及其用途
Song Hypertrophic scars and keloids in surgery: current concepts
Yoo et al. Application of mesenchymal stem cells derived from bone marrow and umbilical cord in human hair multiplication
Çankirili et al. Skin stem cells, their niche and tissue engineering approach for skin regeneration
KR20210097116A (ko) 색소 침착 피부 모델 및 그 제조 방법, 및 피부의 색소 침착을 치료 또는 예방하기 위한 인자의 평가 방법
Xie et al. Induction of dermal fibroblasts into dermal papilla cell-like cells in hydrogel microcapsules for enhanced hair follicle regeneration
Roy et al. Implanting mechanically reprogrammed fibroblasts for aged tissue regeneration and wound healing
Wang et al. Hair follicle stem cells isolated from newborn Yangtze River Delta White Goats
US8334136B2 (en) Method for promoting hair growth or hair regeneration by maintaining or increasing expression of cell-adhesion factor
Schreder et al. Facing towards epidermal stem cells
Wang et al. Human embryonic stem cell-derived melanocytes exhibit limited immunogenicity
JP2023523369A (ja) 白斑モデルの構築方法及びモデルの応用
US20240024369A1 (en) Isolated primary dermal fibroblasts for treating skin conditions
Lombardi et al. Christina Philippeos1, Stephanie Telerman1, Bénédicte Oulès1, Angela O. Pisco1, Tanya J. Shaw2, Raul Elgueta3
Schlüter et al. Burns and Skin Ulcers
Fatima Characterisation of Cutaneous Wound Healing Process in Naked Mole Rats
Mills et al. Bovine coronary region keratinocyte colony formation is supported by epidermal-dermal interactions
JP2019081713A (ja) 毛包幹細胞の未分化状態維持剤
WO2018156903A1 (en) Methods for identifying and isolating cardiac stem cells and methods for making and using them
Wang et al. Stem cells in the skin
Daszczuk Mazurek P, Pieczonka TD, Olczak A, Boryń ŁM and Kobielak K (2020) An Intrinsic Oscillation of Gene Networks Inside Hair Follicle Stem Cells: An Additional Layer That Can Modulate Hair Stem Cell Activities

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

T11 Administrative time limit extension requested

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13 Administrative time limit extension granted

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T13-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

T11 Administrative time limit extension requested

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T11-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13 Administrative time limit extension granted

Free format text: ST27 STATUS EVENT CODE: U-3-3-T10-T13-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

E13 Pre-grant limitation requested

Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000